TSPYL2 and cancer: It is worthy to note that TSPYL2 showed down-regulation in most of the 27 cancers (Supplementary Data Figure S3) and also very weak to strong negative correlation with UBE2C in most of these studied cancers (Table S1 file and Table 2).